Colorectal Cancer

>

Latest News

Data from the colorectal cancer cohort of the KRYSTAL-1 trial support the accelerated approval of adagrasib/cetuximab in KRAS G12C–mutated disease.
FDA Approves Adagrasib/Cetuximab in KRAS G12C-Mutated CRC

June 21st 2024

Data from the colorectal cancer cohort of the KRYSTAL-1 trial support the accelerated approval of adagrasib/cetuximab in KRAS G12C–mutated disease.

Phase 2 data show that vaccination with PolyPEPI1018 may enhance the efficacy of atezolizumab in those with microsatellite stable metastatic CRC.
Multi-Peptide Vaccine Combo Shows Tolerability in Metastatic MSS CRC

June 3rd 2024

5-Year OS Rates Improve After Liver Transplant Plus Chemo CRC With Liver Metastasis
5-Year OS Rates Improve After Liver Transplant Plus Chemo CRC With Liver Metastasis

June 2nd 2024

Treatment with complete mesocolic excision appears to reduce the length of hospital stay compared with conventional surgery in right colon cancer.
Complete Mesocolic Excision Appears Feasible in Right Colon Cancer

May 24th 2024

Investigators may continue to reevaluate the benefits of the AI navigator MyEleanor over time in other patient populations.
AI Tool May Increase Colonoscopy Reengagement

May 24th 2024

More News